A double-blind, randomized, multicenter, placebo-controlled, parallel, dose-titration study to assess the efficacy of lercanidipine 10mg and 20mg once daily p.o. in hypertensive subjects (I or II WHO [World health Organisation]) with elevated body weight.

Trial Profile

A double-blind, randomized, multicenter, placebo-controlled, parallel, dose-titration study to assess the efficacy of lercanidipine 10mg and 20mg once daily p.o. in hypertensive subjects (I or II WHO [World health Organisation]) with elevated body weight.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Lercanidipine (Primary)
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 16 Jul 2007 Status changed from in progress to completed.
    • 14 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top